For the Inventor, By the Inventor

Enter assignee name

Grand Cayman, Cayman Islands

Xwpharma Ltd.

USPTO Granted Patents = 29

EPO Patents = 11

Trademarks = 1

Forward Citations = 13

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Jia-Ning Xiang (15 out of 77 patents)

Jia-ning Xiang (13 out of 13 patents)

Daniel M Canafax (12 out of 13 patents)

4. William W Xiang (12 out of 12 patents)

5. Sami Karaborni (8 out of 30 patents)

6. James Tien (8 out of 8 patents)

7. Xuesong Xu (7 out of 19 patents)

8. Xianbo Liu (6 out of 8 patents)

9. Wai-Si Eng (6 out of 15 patents)

10. Hao-Wei Shih (5 out of 7 patents)

11. Zude Qi (4 out of 6 patents)

12. Dezheng Ning (4 out of 6 patents)

13. Xiaoming Wu (4 out of 4 patents)

14. Xuan Zhang (4 out of 9 patents)

15. Yi Feng (4 out of 7 patents)

29 patents: Sort by Forward Citations

1. 12747199 - Crystalline 4-((L-valyl)oxy)butanoic acid (2026-09-29),

2. 12691090 - Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative (2026-07-28),

3. 12612357 - Methods of synthesizing 4-valyloxybutyric acid (2026-04-28),

4. 12396966 - Pharmaceutical compositions and oral dosage forms of ketamine derivatives (2025-08-26),

5. 12396956 - Modified release compositions of a gamma-hydroxybutyric acid derivative (2025-08-26),

6. 12337066 - Controlled release granulations of water-soluble active pharmaceutical ingredients (2025-06-24),

7. 12234226 - Compounds as nuclear transport modulators and uses thereof (2025-02-25),

8. 12209060 - Ketamine derivatives and compositions thereof (2025-01-28),

9. 12172980 - Compounds as neuronal histamine receptor-3 antagonists and uses thereof (2024-12-24),

10. 12030834 - Methods of synthesizing 4-valyloxybutyric acid (2024-07-09),

11. 11944597 - Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative (2024-04-02),

12. 11925710 - Modified release compositions of a GAMMA-hydroxybutyric acid derivative (2024-03-12),

13. 11905247 - Compounds as neurokinin-1 receptor antagonists and uses thereof (2024-02-20),

14. 11896573 - Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivative (2024-02-13),

15. 11767313 - Compounds as nuclear transport modulators and uses thereof (2023-09-26),

XWPHARMA LTD. is a pharmaceutical company specializing in the research, development, and production of innovative medicines. With a strong focus on quality, safety, and efficacy, XWPHARMA aims to improve patients' lives by providing effective treatments for various medical conditions. Our dedicated team of scientists, researchers, and professionals work tirelessly to discover breakthrough therapies and bring them to market. Visit our website to learn more about our products and commitment to advancing healthcare.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

29 Patents

#30 in Grand Cayman

#40 in Cayman Islands

#22,510 in the World

Grand Cayman, Cayman Islands

Xwpharma Ltd.

Forward Citations = 13

26 inventors:

Jia-Ning Xiang (15 out of 77 patents)

Jia-ning Xiang (13 out of 13 patents)

Daniel M Canafax (12 out of 13 patents)

4. William W Xiang (12 out of 12 patents)

5. Sami Karaborni (8 out of 30 patents)

Please report any incorrect information to [email protected]

Loading…